@marklewismd @NEJM @MSKCancerCenter Same can be said for msi+. Tumor agnostic approval does not equal a guarantee of response. With msi some tumor types don’t respond… and in fact high tmb msi+ pts drive the response https://t.co/PNNUc8nlyF https://t.co/
So far, Altmetric has seen
365 X posts from 279 X users, with an upper bound of 5,550,669 followers.
5,107 followers
2,215 followers
@RenoHemonc @AstraZeneca @EileenMOReilly @MPishvaian https://t.co/L3QvLeIV6o some indirect evidence indel load correlating more than SNV to IO response?@GeneCollector We tried to show something similar in the past in lung https://t.co/iPnE90Og5d
1,138 followers
RT @EthanSokol: New paper out showing that not all MSI-H tumors are created equal: https://t.co/rhFrKtew3n
112 followers
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response. https://t.co/8S7lBM9Y62